Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension

• Cornelia Schuster,

  Affiliations Department of Oncology, Haukeland University Hospital, Bergen, Norway, Section for Pathology, The Gade Institute, University of Bergen, Bergen, Norway, Department of Pathology, Haukeland University Hospital, Bergen, Norway

  ⨯
• Hans P. Eikesdal,

  Affiliation Department of Oncology, Haukeland University Hospital, Bergen, Norway

  ⨯
• Hanne Puntervoll,

  Affiliations Section for Pathology, The Gade Institute, University of Bergen, Bergen, Norway, Department of Pathology, Haukeland University Hospital, Bergen, Norway

  ⨯
• Jürgen Geisler,

  Affiliations Division of Clinical Medicine and Laboratory Sciences, Institute of Clinical Medicine, University of Oslo, Oslo, Norway, Department of Oncology, Akershus University Hospital, Lørenskog, Norway

  ⨯
• Stephanie Geisler,

  Affiliation Department of Oncology, Haukeland University Hospital, Bergen, Norway

  ⨯
• Daniel Heinrich,

  Affiliations Division of Clinical Medicine and Laboratory Sciences, Institute of Clinical Medicine, University of Oslo, Oslo, Norway, Department of Oncology, Akershus University Hospital, Lørenskog, Norway

  ⨯
• Anders Molven,

  Affiliations Section for Pathology, The Gade Institute, University of Bergen, Bergen, Norway, Department of Pathology, Haukeland University Hospital, Bergen, Norway

  ⨯
• Per E. Lønning,

  Affiliation Department of Oncology, Haukeland University Hospital, Bergen, Norway

  ⨯
• Lars A. Akslen,

  Affiliations Section for Pathology, The Gade Institute, University of Bergen, Bergen, Norway, Department of Pathology, Haukeland University Hospital, Bergen, Norway

  ⨯
• Oddbjørn Straume

  * E-mail: oddbjorn.straume@helse-bergen.no

  Affiliation Department of Oncology, Haukeland University Hospital, Bergen, Norway

  ⨯